Resveratrol Does Not Benefit Patients with NAFLD Reporting in Clinical Hepatology and Gastroenterology, researchers find that eight weeks administration of resveratrol did not induce therapeutic benefits in males with established NAFLD, weighed against placebo. Caution is normally warranted for use in obesity with chronic liver disease until further research determines safety.. AGA’s journals highlight important updates into remedies for cirrhosis, NAFLD Cirrhosis and nonalcoholic fatty liver disease are two serious liver conditions with limited pharmacological remedies. The December problems of AGA's journals – – Clinical Gastroenterology and Hepatology and Gastroenterology – – highlight important updates into remedies for these two debilitating diseases.Problems and Adverse Events No complications of otitis mass media, including local cellulitis, perichondritis, mastoiditis, and intracranial problems, were reported through the first 14 days of follow-up . A complete of 16 children who received eardrops acquired pain or discomfort when the drops were administered, and 2 had a local rash. Gastrointestinal symptoms created in 18 children who received oral antibiotics, and rash created in 3 . During six months of follow-up, fewer kids treated with eardrops got episodes of otorrhea that persisted for 4 weeks or more, as compared with those treated with oral antibiotics or those designated to initial observation .